ArticleClinical lung cancer2026

High Programmed Death-Ligand 1 Expression is Associated With a Shorter Progression Free Survival in ALK-Rearranged Lung Cancer Patients Treated With First Line Tyrosine Kinase Inhibitors.

Yunan Nie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.